Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Liviu Klein, MDRichard Cheng, MD
Description
Summary
Keywords
Eligibility
Locations
Lead Scientists at UCSF
- Liviu Klein, MD
My clinical interests are heart failure and cardiac arrhythmias in patients with heart failure. Having advanced training in both heart failure and electrophysiology, I practice an integrated approach in treating patients with heart failure and cardiac arrhythmias. I am also interested in cardiac recovery using electrical (i.e. cardiac resynchronization) and mechanical (i.e. - Richard Cheng, MD
Dr. Richard Cheng is a cardiologist who specializes in the comprehensive care of patients with heart failure. Having trained in both advanced heart failure and interventional cardiology, his approach combines medical therapy optimization with minimally invasive surgeries and novel devices that can improve heart function.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ancora Heart, Inc.
- ID
- NCT04331769
- Study Type
- Interventional
- Last Updated